CARE Ratings per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹64.15₹57.06₹45.89₹33.77₹28.17
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹63.94₹56.83₹45.69₹33.67₹28.17
₹310.33₹310.33₹269.37₹240.23₹226.33
₹172.60₹157.44₹134.41₹111.11₹93.94
—₹49.15₹41.08₹30.44₹27.69
₹46.39₹46.39₹36.15₹27.37₹23.82
—₹19.42₹18.35₹22.41₹20.12
3.03.03.03.03.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CARERATING₹1,610.00

CARE Ratings Limited

· Banking & Finance
₹ CrorePeersICRAMcap ₹4,838 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS28.1733.7745.8957.0664.15
Diluted EPS28.1733.6745.6956.8363.94
Book Value per Share226.33240.23269.37310.33310.33
Revenue per Share93.94111.11134.41157.44172.60
Cash Flow per Share27.6930.4441.0849.15—
Free Cash Flow per Share23.8227.3736.1546.3946.39
Dividends per Share20.1222.4118.3519.42—
Shares Outstanding (cr)3.03.03.03.03.0
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.